Seeking Celiac Patients
at the University of Chicago Medical Center to Participate in Study
(if you are not currently a patient, you may schedule an appointment for a consultation)
The University of Chicago Celiac Disease Center is conducting a study to evaluate the performance of a new test for the antibodies associated with celiac disease. Typically, people with celiac disease have elevated levels of certain antibodies in the blood, including tissue transglutaminase (tTG), anti-endomysium antibodies (EMA), and deamidated gliadin peptides (DGP).
To qualify for this study, you must be a patient at the University of Chicago Medical Center. To schedule an appointment for a new patient consultation, please call (773) 702-3572. You must have positive blood tests for the antibodies associated with celiac disease, or you must have been recently diagnosed by a scope with biopsies (upper endoscopy).
Subjects who agree to participate in this study will have about 1 teaspoon (3 mL) of blood drawn at the University of Chicago Medical Center.
For participation in this study you will receive $50 in the form of a check.
If you would like to participate in this study or have further questions about the study, please email or call research coordinator, NurAlima Grandison, at ngrandison@uchicago.edu or (773) 702-3572.
The study will be open until 7/31/2012.
